Grifols SA GIFLF
Annual
Quarterly
No annual revenue total was found in Grifols SA's SEC filings.
Grifols SA (GRFS) files with the SEC under industry code 2834, Pharmaceutical Preparations.
Revenue
—
Net income
—
Operating cash flow
—
Free cash flow
—
EPS
—
Dividend per share
None
Shares outstanding
—
Net cash
—
Operating margin
—
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- GRFS (Nasdaq), GIFLF (OTC), GIFOF (OTC), GIKLY (OTC)
- Headquarters
- New York, NY
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1438569
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 6-K | Current report (foreign issuer) | Nov 2, 2026 | Nov 2, 2026 |
| 6-K | Current report (foreign issuer) | Nov 2, 2026 | Nov 2, 2026 |
| 6-K | Current report (foreign issuer) | Jul 30, 2026 | Jul 30, 2026 |
| 6-K | Current report (foreign issuer) | Jul 29, 2026 | Jul 28, 2026 |
| 6-K | Current report (foreign issuer) | Jun 22, 2026 | Jun 22, 2026 |
| 6-K | Current report (foreign issuer) | Jun 18, 2026 | Jun 18, 2026 |
All 463 Grifols SA SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.